[Precise immunological classification guidance for early initiation of antiviral therapy in patients with chronic HBV infection].

Zhao, S X; Chang, C D; Nan, Y M

Zhao, S X; Chang, C D; Nan, Y M.

Affiliation

Zhao SX; Department of Traditional and Western Medical Hepatology, the Third Hospital of Hebei Medical University, the Key Laboratory of Hepatic Fibrosis Mechanisms of Chronic Liver Diseases in Hebei Province, Shijiazhuang 050051, China.
Chang CD; Department of Traditional and Western Medical Hepatology, the Third Hospital of Hebei Medical University, the Key Laboratory of Hepatic Fibrosis Mechanisms of Chronic Liver Diseases in Hebei Province, Shijiazhuang 050051, China.
Nan YM; Department of Traditional and Western Medical Hepatology, the Third Hospital of Hebei Medical University, the Key Laboratory of Hepatic Fibrosis Mechanisms of Chronic Liver Diseases in Hebei Province, Shijiazhuang 050051, China.

Zhonghua Gan Zang Bing Za Zhi ; 31(3): 228-232, 2023 Mar 20.

Article de Zh | MEDLINE | ID: mdl-37137845

Sujet(s)
Mots clés

Antiviral therapy; Hepatitis B virus; Immunology; Infection; Phases

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Hépatite B chronique Type d'étude: Guideline Limites: Humans Langue: Zh Journal: Zhonghua Gan Zang Bing Za Zhi Sujet du journal: GASTROENTEROLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google